Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest update is out from Raily Aesthetic Medicine International Holdings Limited ( (HK:2135) ).
Raily Aesthetic Medicine International Holdings Limited announced a deemed disposal of equity interest in a subsidiary through an investment agreement with two investors. The transaction involves a capital injection by the investors, resulting in a significant reduction of Hangzhou Raily’s equity in the Target Company from 100% to 30%. This move is part of a strategy to reduce accumulated losses and improve the financial position of the subsidiary. The transaction is classified as a discloseable transaction under Hong Kong’s Listing Rules, requiring an announcement but not shareholder approval.
More about Raily Aesthetic Medicine International Holdings Limited
Raily Aesthetic Medicine International Holdings Limited operates in the aesthetic medicine industry, focusing on providing medical aesthetic services. The company is incorporated in the Cayman Islands and is listed on the Hong Kong Stock Exchange.
Average Trading Volume: 136,205
Technical Sentiment Signal: Sell
Current Market Cap: HK$69.08M
For a thorough assessment of 2135 stock, go to TipRanks’ Stock Analysis page.